Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes

Rheumatology International

Volumn 23, Issue 6, 2003, Pages 282-288

  Lee, Yun Jong ^a   Lee, Eun Bong ^a   Kwon, Young Ee ^a   Lee, Jung Jin ^a   Cho, Woo Shin ^b   Kim, Hyun A ^a   Song, Yeong Wook ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

Chondrocyte; Estrogen; MMP 1; MMP 13; MMP 3; Osteoarthritis; TIMP 1

Indexed keywords

COLLAGEN TYPE 2; COLLAGENASE 3; DYE; ESTRADIOL; ESTROGEN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CELL CULTURE; CHONDROPROTECTION; COLLAGEN DEGRADATION; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ESTRADIOL; FEMALE; HUMANS; INTERLEUKIN-1; MATRIX METALLOPROTEINASES; MIDDLE AGED; OSTEOARTHRITIS, KNEE; POSTMENOPAUSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344686404     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-003-0312-5     Document Type: Article

References (33)

1. Felson DT, Nevitt CM (1998) The effects of estrogen on osteoarthritis. Curr Opin Rheumatol 10:269-272
2. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF (1989) Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84:678-685
3. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP (1994) Excess of metalloproteinases over tissue inhibitor of metalloproteinase may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 70:807-815
4. Kapila S, Xie Y (1998) Targeted induction of collagenase and stromelysin by relaxin in unprimed and beta-estradiol-primed diarthrodial joint fibrocartilagenous cells but not in synovitis. Lab Invest 78:925-938
5. Pezzetti F, De Mattei M, Caruso A, Cadossi R, Zucchini P, Carinci F, Traina GC, Sollazzo V (1999) Effects of pulsed electromagnetic fields on human chondrocytes: an in vitro study. Calcif Tissue Int 65:396-401
6. Murawaki Y, Koda M, Yamada S, Kawasaki H, Shima H, Burkhardt H (1993) Serum collagenase activity in patients with chronic liver disease. J Hepatol 18:328-334
7. Spector TD, Nandra D, Hart DJ, Doherty M (1997) Is hormone replacement therapy protective for hand and knee osteoarthritis in women? The Chingford Study. Ann Rheum Dis 56:432-434
8. Zhang Y, McAlindon T, Hannan MT, Chaisson CE, Klein R, Wilson PW, Felson DT (1998) Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: The Framingham Study. Arthritis Rheum 41:1867-1873
9. Hart DJ, Doyle DV, Spector TD (1999) Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: the Chingford Study. Arthritis Rheum 42:17-24
10. Hannan MT, Felson DT, Anderson JJ, Naimark A, Kannel WB (1990) Estrogen use and radiographic osteoarthritis of the knee in women. The Framingham Osteoarthritis Study. Arthritis Rheum 33:525-532
11. Samanta A, Jones A, Regan M, Wilson S, Doherty M (1993) Is osteoarthritis in women affected by hormonal changes or smoking? Br J Rheumatol 32:366-370
12. Erb A, Brenner H, Gunther KP, Sturmer T (2000) Hormone replacement therapy and patterns of osteoarthritis: baseline data from the Ulm Osteoarthritis Study. Ann Rheum Dis 59:105-109
13. Tsai CL, Liu TK, Chen TJ (1992) Estrogen and osteoarthritis: a study of synovial estradiol and estradiol receptor binding in human osteoarthritis knees. Biochem Biophys Res Commun 183:1287-1291
14. Cauley JA, Kwoh CK, Egeland G, Nevitt MC, Cooperstein L, Rohay J, Towers A, Gutai JP (1993) Serum sex hormones and severity of osteoarthritis of the hand. J Rheumatol 20:1170-1175
15. Sowers MF, Hochberg M, Crabbe JP, Muhich A, Crutchfield M, Updike S (1996) Association of bone mineral density and sex hormone levels with osteoarthritis of the hand and knee in premenopausal women. Am J Epidemiol 143:38-47
16. Roaner I, Goldberg VM, Moskowitz RW (1979) Effects of estrogens on cartilage and experimentally induced osteoarthritis. Arthritis Rheum 22:52-58
17. Rosner IA, Malemud CJ, Godberg VM, Papay RS, Getzy L, Moskowitz RW (1982) Pathologic and metabolic responses of experimental osteoarthritis to estradiol and an estradiol antagonist. Clin Orthop 171:280-286
18. Tsai CL, Liu TK (1992) Inhibition of estradiol-induced early osteoarthritic changes by tamoxifen. Life Sci 50:1943-1951
19. Levrant SG, Barnes RB (1994) Pharmacology of estrogens. In: Lobo RA (ed) Treatment of postmenopausal woman. First edn. Raven Press, New York, pp 57-89
20. Hsueh AW, Billing H (1995) Ovarian hormone synthesis and mechanism of action. In: DeGroot LJ (ed) Endocrinology. Third edn. Saunders, Philadelphia, pp 2019-2030
21. Challis JR, Davies J, Ryan KJ (1973) The concentrations of progesterone, estrone and estradiol-17 beta in the plasma of pregnant rabbits. Endocrinology 93:971-976
22. Kahle P, Saal JG, Schaudt K, Zacher J, Fritz P, Pawelec G (1992) Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis 51:731-734
23. Manicourt DH, Poilvache P, Van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ (2000) Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum 43:281-288
24. Goldring MB (1999) The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 40:1-11
25. Wluka AE, Davis SR, Bailey M, Stuckey SL, Cicuttini FM (2001) Users of oestrogen replacement therapy have more knee cartilage than non-users. Ann Rheum Dis 60:332-336
26. Nevitt MC, Felson DT, Williams EN, Grady D (2001) The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/ Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 44:811-818
27. Ham KD, Loeser RF, Lindgren BR, Carlson CS (2002) Effects of long-term estrogen replacement therapy on osteoarthritis severity in cynomolgus monkeys. Arthritis Rheum 46:1956-1964
28. Su S, Grover J, Roughley PJ, DiBattista JA, Martel-Pelletier J, Pelletier JP, Zafarullah M (1999) Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints. Rheumatol Int 18:183-191
29. Ushiyama T, Ueyama H, Inoue K, Ohkubo I, Hukuda S (1999) Expression of genes for estrogen receptors alpha and beta in human articular chondrocytes. Osteoarthritis Cartilage 7:560-566
30. Kelly MJ, Levin ER (2001) Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12:152-156
31. Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE (2000) Interleukin-1 induction of collagenase-3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-JUN N-terminal kinase, and nuclear factor κB. Arthritis Rheum 43:801-811
32. Fernihough JK, Richmond RS, Carlson CS, Cherpes T, Holly JM, Loeser RF (1999) Estrogen replacement therapy modulation of the insulin-like growth factor system in monkey knee joints. Arthritis Rheum. 42:2103-2111
33. Richmond RS, Carlson CS, Register TC, Shanker G, Loeser RF (2000) Functional estrogen receptors in adult articular cartilage: estrogen replacement therapy increases chondrocyte synthesis of proteoglycans and insulin-like growth factor binding protein 2. Arthritis Rheum 43:2081-2090